摘要
目的 探讨瑞舒伐他汀钙联合普罗布考致横纹肌溶解并急性肝肾损伤的处置措施。方法 分析1例瑞舒伐他汀钙和普罗布考联合使用后发生横纹肌溶解并急性肝肾损伤患者的诊疗经过,结合文献探讨其发生机制及应对措施。结果 患者联合使用瑞舒伐他汀钙和普罗布考14 d后,出现肌酸激酶、转氨酶和血清肌酐值快速升高,立即停用2种降脂药物,积极补液、利尿并行多次血液透析后,患者肌酸激酶、转氨酶和血清肌酐值逐步下降,并于停药后34d恢复之前水平。结论 联合使用瑞舒伐他汀钙、普罗布考发生横纹肌溶解并急性肝肾损伤后,应立即停药,积极补液,必要时行血液透析。
Objective To explore ways to treat rhabdomyolysis along with acute liver injury and acute kidney injury induced by rosuvastatin calcium and probucol.Methods The process of treating one case of rhabdomyolysis along with acute liver injury and acute kidney injury due to rosuvastatin calcium and probucol was analyzed based on literature review.The mechanism by which rosuvastatin calcium and probucol induced rhabdomyolysis complicated with acute liver injury and acute kidney injury was investigated.Results The patient was diagnosed with rhabdomyolysis along with acute liver injury and acute kidney injury 14 days after rosuvastatin calcium and probucol were used.These two drugs were withdrawn on the same day and the patient was given sufficient rehydration,dieresis and hemodialysis.The level of CK and indexes of the liver and kidney of the patient decreased gradually and returned to the previous level 34 days after drug withdrawal.Conclusion The use of rosuvastatin calcium and probucol should be discontinued immediately in case of rhabdomyolysis along with acute liver injury and acute kidney injury.The patient should be given active fluid rehydration and hemodialysis if it is necessary.
作者
陈静
成华
刘宪军
CHEN Jing;CHENG Hua;LIU Xianjun(Department of Medicine,Beijing Luhe Hospital,Capital Medical University,Beijing 101149,China)
出处
《中国药物警戒》
2022年第7期792-794,共3页
Chinese Journal of Pharmacovigilance
基金
首都临床特色应用研究(Z181100001718144)。
关键词
瑞舒伐他汀钙
普罗布考
横纹肌溶解
急性肝肾损伤
药品不良反应
rosuvastatin calcium tablets
probucol tablets
rhabdomyolysis
acute liver injury and acute kidney injury
adverse drug reaction
